Antibiotics have transformed modern medicine. They are essential for treating infectious
diseases and enable vital therapies and procedures. However, despite this success, their …

Acinetobacter baumannii is a Gram-negative ESKAPE microorganism that poses a threat to
public health by causing severe and invasive (mostly nosocomial) infections linked with high …

[编者按] 鲍曼不动杆菌已成为21 世纪临床重要致病茵. 鲍曼不动杆菌基因组研究发现其具有快速
获得和传播耐药性的能力, 多重耐药, 广泛耐药, 全耐药鲍曼不动杆菌已呈世界性流行 …

Antimicrobial resistance (AMR) is emerging as the next potential pandemic. Different
microorganisms, including the bacteria Acinetobacter baumannii, Clostridioides difficile …

Acinetobacter baumannii has become a major concern for scientific attention due to
extensive antimicrobial resistance. This resistance causes an increase in mortality rate …

Being a multidrug-resistant and an invasive pathogen, Acinetobacter baumannii is one of
the major causes of nosocomial infections in the current healthcare system. It has been …

We characterized two bacteriophages, ΦFG02 and ΦCO01, against clinical isolates of
Acinetobacter baumannii and established that the bacterial capsule is the receptor for these …

The COVID-19 pandemic has generated an overuse of antimicrobials in critically ill patients.
Acinetobacter baumannii frequently causes nosocomial infections, particularly in intensive …

Objectives Acinetobacter baumannii is an opportunistic pathogen which has recently been
categorized as a high risk pathogen by World Health Organisation (WHO). The microbe has …

Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …